Introduction: Gut microbiota modulation by nutritional procedures has become a feasible therapeutic target in the management of obesity and non-alcoholic fatty liver disease (NAFLD) (1). Recently, Akkermansia muciniphila has been considered as a potential probiotic due to its protective effect in obesity development (2). Besides, the flavonoid quercetin has shown an anti-inflammatory, antioxidant and prebiotic capacity, highlighting a great therapeutic potential in NAFLD (3). This study aims to evaluate the effect of gut microbiota modulation by the feasible symbiotic quercetin and A. muciniphila combined with nutritional intervention in the development of early obesity-related NAFLD in an in vivo model.

Methods: 21-days old Wistar rats were fed with a high-fat diet (HFD) or a control (C) diet for 6 weeks. Afterwards, all animals were fed with a C diet supplemented or not with quercetin and A. muciniphila (administered daily by oral gavage) for 3 weeks. Faecal samples were analyzed by qPCR and sequenced by Illumina MiSeq System to determine gut microbiota composition. Statistical significance was determined by nonparametric Kruskal-Wallis test followed by Mann-Whitney U test (p<0.05).

Results: After 6 weeks, HFD intake triggered a lower concentration of the total bacteria DNA in comparison to C, but increased gut microbiota diversity calculated by the Shannon diversity index. Metagenomic analysis demonstrated an HFD-related gut dysbiosis, showing a significant increase of Firmicutes, Proteobacteria and Actinobacteria phyla, while, Bacteroidetes and Cyanobacteria showed an opposite pattern. At genus level, HFD increased the relative abundance of Adlercreutzia, Allobaculum, Bifidobacterium, Bilophila, Blautia, Clostridium, Enterococcus, Lactobacillus, Oscillospira, Rothia and Streptococcus genera. In contrast, Coprobacillus, Coprococcus, Phascolartobacterium, Prevotella, Roseburia, Sutturella and Turicibacter were reduced. Principal coordinates analysis (PCoA) revealed that the bacterial communities of HFD-fed rats clustered separately from those of C group. After 3 weeks, the nutritional intervention together with quercetin and A. muciniphila supplementation reversed the gut dysbiosis associated to HFD, tending to increase total bacteria counts and decrease Shannon diversity index. Moreover, a notable increase in the abundance of Cyanobacteria phylum, as well as a decrease in Actinobacteria phylum was detected. Additionally, several differences at genus level were observed in the symbiotic supplemented groups that were not detected with the administration of any of the treatments alone. The symbiotic reduced the detection of Lactococcus and Lactobacillus genera, whereas Oscillospira was highly abundant in both supplemented groups. To determine the effect of quercetin and A. muciniphila administration on bacterial communities a PCoA was conducted, showing that the individuals receiving the symbiotic tended to cluster together and separated from the other groups.

Conclusion: Dietary intervention combined with A. muciniphila and quercetin administration seems to counteract HFD-associated dysbiosis and subsequent obesity related-NAFLD in a juvenile rat model. 

Supported by BFU2017-87960-R; GRS1888/A/18. CIBERehd is funded by Instituto de Salud Carlos III.


1.	Polyzos SA, Kountouras J, Mantzoros CS (2019) Metabolism 92, 82-97
2.	Depommier C, Everard A, Druart C et al. (2019) Nat Med 25, 1096–103 
3.	Porras D, Nistal E, Martínez-Flórez S, et al. (2019) Mol Nutr Food Res 63

A dietary intervention with Akkermansia muciniphila and quercetin supplementation reshapes gut microbiota composition in an in vivo model of early obesity related non-alcoholic fatty liver disease

The gastrointestinal tract is amongst the most densely populated ecosystems on earth, home to an abundant and diverse collection of microbial species, not just bacteria but also Archaea, viruses, fungi etc. Significant interest in this area has been sparked in recent years by an appreciation of the importance of the gut microbiota in the health of the host, and this has led to the microbiome of humans and animals being investigated in depth. Studies have drawn links between host nutrition, the gut microbiota and metabolic and immune functions, which in consequence affect physiology.



The first investigations of the structure of the microbiota were culture-based, however the introduction of sequencing technologies such as Sanger sequencing and subsequent development of 454 sequencing and metagenomics approaches have become the mainstay of microbiota studies. The creation of reference databases and analysis software has provided invaluable tools for assigning taxonomy to generated data. Great progress in characterising the structure of the microbiome recently has paved the way for ongoing and future studies on the functional interactions between the microbiota and the host. Studies on the function of the microbiota are critical in understanding the role of the microbiota in human homeostasis and disease pathogenesis.



The conference will be presenting the latest advancements in gut microbiome and health research. It will bring together experts who are driving technological advancements and striving to understand how nutrition impacts gut microbiome and the interactions between gut microbiome and health.



[https://www.nutritionsociety.org/](https://www.nutritionsociety.org/)

[@NutritionSoc](https://twitter.com/NutritionSoc)

[Member-Connect](https://membership.nutritionsociety.org/signin?message=loginRequired&next=https://membership.nutritionsociety.org)

[Cambridge Core](https://www.cambridge.org/core/societies/nutrition-society)

Recordings of the conference will be available until 13 April 2021.